Pacira BioSciences, Inc.
PCRX
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
15 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$24.67
Price+3.53%
$0.84
1Y
Price
Market Cap
$970.394m
Small
Price/Earnings 3y Avg5y Avg
9.5x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+16.6%
EBITDA Margin+1.6%
Net Profit Margin+12.9%
Free Cash Flow Margin+16.6%
EBITDA Margin+1.6%
Net Profit Margin+12.9%
Free Cash Flow MarginRevenue
$734.864m
+1.2%
1y CAGR+2.9%
3y CAGR+2.5%
5y CAGREarnings
$5.138m
-27.0%
1y CAGR-85.7%
3y CAGR-23.4%
5y CAGREPS
$0.12
-25.0%
1y CAGR-86.4%
3y CAGR-24.3%
5y CAGRBook Value
$653.893m
$1.209b
Assets$554.641m
Liabilities$411.179m
DebtDebt to Assets
34.0%
3.5x
Debt to EBITDAFree Cash Flow
$132.706m
-2.9%
1y CAGR+0.6%
3y CAGR+5.7%
5y CAGRNo items found.
Press Releases
Statements and updates from the company